RenovoRx, Inc. (RNXT) News
Track canonical SquawkNews coverage tagged to RNXT, RenovoRx, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
RenovoRx Raises FY2026 Sales Guidance
RenovoRx raises FY2026 sales outlook to $3.750M-$4.250M
EARNINGS | Aug 12, 2026, 08:15 PM UTC
L
RNXT Reports Record Q2 2026 Results
RNXT reports record second quarter 2026 results with 61% sequential revenue growth
EARNINGS | Aug 12, 2026, 08:05 PM UTC
M
RenovoRx Expands RenovoCath Use To Solid Tumors
RenovoRx expands use of RenovoCath to solid tumors
EQUITY | Aug 06, 2026, 12:31 PM UTC
L
RNXT - RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET - Click
RNXT - RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
EARNINGS | Jul 29, 2026, 12:30 PM UTC